Schizophrenia News and Research

Latest Schizophrenia News and Research

Breakthrough in strategy used to develop new pharmacological treatments for schizophrenia

In one of the first instances of targeted drug design in psychiatric treatment, University of Pittsburgh researchers have found an experimental agent that shows promise in addressing working memory impairments that occur in schizophrenia.

1 Dec 2008

People with lower IQs may have greater risk of mental disorders

Researchers have hypothesized that people with lower IQs may have a higher risk of adult mental disorders, but few studies have looked at the relationship between low childhood IQ and psychiatric disorders later in life.

1 Dec 2008

Roche to acquire Memory Pharmaceuticals

Roche and Memory Pharmaceuticals has announced that the two companies have signed a definitive merger agreement for Roche to acquire all the outstanding shares of Memory Pharmaceuticals in an all-cash transaction for an aggregate price of approximately USD 50 million.

25 Nov 2008

New plan to tackle off-label prescribing

Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval - a practice known as off-label prescribing.

24 Nov 2008

Stress found to impair decision making in rats

Neuroscientists from the University of Washington have found that a single exposure to uncontrollable stress impairs decision making in rats for several days, making them unable to reliably seek out the larger of two rewards.

18 Nov 2008

Patients with depressive disorders or schizophrenia more likely to re-attempt suicide

Men and women who have tried to kill themselves and are suffering from unipolar disorder (major depression), bipolar disorder (manic depression) or schizophrenia are at a very high risk of committing suicide within a year of their first attempt, concludes a study published today on bmj.com.

18 Nov 2008

Kynurenic acid in brain shows potential as schizophrenia target

New research has traced elevated levels of a specific compound in the brain to problem-solving deficits in patients with schizophrenia.

18 Nov 2008

Breakthrough in cellular analysis

Like skilled assassins, many diseases seem to know exactly what types of cells to attack.

16 Nov 2008

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

Swissmedic, the Swiss agency for therapeutic products, has approved Zevtera (ceftobiprole medocaril) for the treatment of complicated skin and soft tissue infections, including diabetic foot infections which have not spread to the bone.

13 Nov 2008

Breakthrough in cell-type analysis offers new ways to study development and disease

Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce - their 'translational profile,' in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.

13 Nov 2008

Researchers uncover beneficial mechanism of the helpful "Dr. Jekyll" side of the Cdk5 protein

Researchers at UT Southwestern Medical Center have uncovered new insights into the "Dr. Jekyll and Mr. Hyde" nature of a protein that stimulates stem-cell maturation in the brain but, paradoxically, can also lead to nerve-cell damage.

12 Nov 2008

New study focuses on adolescents and young adults at risk for psychosis

Emory University in Atlanta is playing a key role in the largest, most comprehensive study ever funded by the National Institute of Mental Health (NIMH) of adolescents and young adults at risk for developing a psychotic disorder.

12 Nov 2008

Protein can nurture or devastate brain cells, depending on its 'friends,' UT Southwestern researchers find

11 Nov 2008

One in five U.S. hospital admissions are for patients with mental disorders

According to the latest figures from the Agency for Healthcare Research and Quality (AHRQ) in the United States, one in five hospital admissions are for patients with mental disorders.

11 Nov 2008

History of serious mental illness linked to stillborn babies

New research has revealed that women with a history of serious mental illness are much more likely to have babies that are stillborn or die within the first month of life.

10 Nov 2008

Psychiatric illness linked to stillbirth and newborn deaths

Women with a history of serious mental illness are much more likely to have babies that are stillborn or die within the first month of life, new research reveals.

From The University of Manchester 10 Nov 2008

Interaction between gene variants may alter brain function in schizophrenia

A collaborative study led by investigators from Massachusetts General Hospital (MGH) is giving what may be the first look at how interactions between genes underlie a key symptom of schizophrenia, impaired working memory.

8 Nov 2008

Treatments for seasonal affective disorder (SAD)

Bright white light therapy has been used to treat seasonal affective disorder (SAD) for more than 20 years.

7 Nov 2008

Discovery of new target in brain for treating schizophrenia

Research from the University of Pittsburgh could expand the options for controlling schizophrenia by identifying a brain region that responds to more than one type of antipsychotic drug.

6 Nov 2008

Research looks at differential rates of psychoses by ethnicity

Researchers examining the occurrence of psychoses among migrant groups have shown a raised incidence for all black and ethnic minority subgroups compared with white British counterparts, and reveal that the risk of psychoses for first and second generations varies by ethnicity.

5 Nov 2008